Bausch Health Cos ROE 2010-2024 | BHC

Current and historical return on equity (ROE) values for Bausch Health Cos (BHC) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Bausch Health Cos ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2024-09-30 $-0.18B $-0.24B 98.21%
2024-06-30 $-0.47B $-0.23B 262.40%
2024-03-31 $-0.46B $-0.17B 827.27%
2023-12-31 $-0.59B $-0.08B -2391.92%
2023-09-30 $-0.96B $-0.24B -873.47%
2023-06-30 $-0.19B $0.27B -67.09%
2023-03-31 $-0.36B $0.15B -130.89%
2022-12-31 $-0.23B $0.26B -111.80%
2022-09-30 $0.25B $0.43B 198.83%
2022-06-30 $0.04B $0.25B -301.75%
2022-03-31 $-0.41B $-0.14B 176.76%
2021-12-31 $-0.95B $-0.03B 419.47%
2021-09-30 $-1.17B $-0.14B 1766.04%
2021-06-30 $-1.29B $-0.61B -980.57%
2021-03-31 $-1.02B $-0.12B -242.09%
2020-12-31 $-0.56B $0.61B -86.29%
2020-09-30 $-1.92B $0.66B -245.99%
2020-06-30 $-2.04B $0.55B -162.40%
2020-03-31 $-1.89B $0.79B -105.27%
2019-12-31 $-1.79B $1.14B -78.05%
2019-09-30 $-0.62B $2.56B -22.73%
2019-06-30 $-0.92B $2.69B -31.84%
2019-03-31 $-1.62B $2.78B -52.27%
2018-12-31 $-4.15B $2.82B -117.40%
2018-09-30 $-3.29B $3.24B -76.26%
2018-06-30 $-1.64B $3.56B -33.73%
2018-03-31 $-0.81B $4.52B -16.17%
2017-12-31 $2.40B $5.94B 49.60%
2017-09-30 $1.38B $5.42B 32.95%
2017-06-30 $-1.14B $4.03B -29.39%
2017-03-31 $-1.41B $3.99B -33.24%
2016-12-31 $-2.41B $3.26B -51.50%
2016-09-30 $-2.28B $4.27B -42.45%
2016-06-30 $-1.01B $5.40B -17.10%
2016-03-31 $-0.76B $5.78B -12.29%
2015-12-31 $-0.29B $6.03B -4.54%
2015-09-30 $0.60B $6.47B 9.55%
2015-06-30 $0.82B $6.56B 13.83%
2015-03-31 $1.00B $6.58B 17.73%
2014-12-31 $0.88B $5.40B 16.60%
2014-09-30 $0.50B $5.23B 9.54%
2014-06-30 $-0.75B $5.37B -14.30%
2014-03-31 $-0.86B $5.20B -16.24%
2013-12-31 $-0.87B $5.23B -17.69%
2013-09-30 $-1.08B $5.06B -23.89%
2013-06-30 $-0.10B $5.70B -2.33%
2013-03-31 $-0.13B $3.59B -3.54%
2012-12-31 $-0.12B $3.72B -3.04%
2012-09-30 $0.03B $3.79B 0.75%
2012-06-30 $0.06B $3.70B 1.58%
2012-03-31 $0.14B $4.08B 3.36%
2011-12-31 $0.16B $3.93B 3.67%
2011-09-30 $0.07B $4.01B 1.57%
2011-06-30 $-0.18B $4.67B -3.61%
2011-03-31 $-0.20B $4.71B -4.87%
2010-12-31 $-0.21B $4.91B -6.42%
2010-09-30 $-0.10B $5.35B -4.42%
2010-06-30 $0.14B $1.36B 10.77%
2010-03-31 $0.13B $1.34B 10.22%
2009-12-31 $0.18B $1.35B 13.87%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $3.012B $8.757B
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.044B 6.25
Dr Reddy's Laboratories (RDY) India $11.978B 22.92
BridgeBio Pharma (BBIO) United States $4.260B 0.00
Amphastar Pharmaceuticals (AMPH) United States $2.097B 12.61
Supernus Pharmaceuticals (SUPN) United States $1.962B 26.71
Taysha Gene Therapies (TSHA) United States $0.434B 30.29
Personalis (PSNL) United States $0.261B 0.00
Assembly Biosciences (ASMB) United States $0.098B 0.00
Sol-Gel Technologies (SLGL) Israel $0.012B 0.00
Evoke Pharma (EVOK) United States $0.007B 0.00
Teligent (TLGT) United States $0.000B 0.00